Detalles de la búsqueda
1.
Differential Effects of Genetic Polymorphism on Comorbid Disease in Metabolic Dysfunction-Associated Steatotic Liver Disease.
Clin Gastroenterol Hepatol;
2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38604296
2.
The greater impact of PNPLA3 polymorphism on liver-related events in Japanese non-alcoholic fatty liver disease patients: A multicentre cohort study.
Liver Int;
43(10): 2210-2219, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37470077
3.
Attenuated effect of PNPLA3 on hepatic fibrosis by HSD17B13 in Japanese patients with non-alcoholic fatty liver disease.
Liver Int;
40(7): 1686-1692, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32342668
4.
HOMA-IR: An independent predictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver disease.
J Gastroenterol Hepatol;
34(8): 1390-1395, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30600551
5.
Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis.
J Gastroenterol Hepatol;
34(9): 1626-1632, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30668889
6.
Insulin resistance increases the risk of incident type 2 diabetes mellitus in patients with non-alcoholic fatty liver disease.
Hepatol Res;
48(3): E42-E51, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28628263
7.
Prevalence of pruritus in patients with chronic liver disease: A multicenter study.
Hepatol Res;
48(3): E252-E262, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28877392
8.
Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study.
BMC Gastroenterol;
17(1): 96, 2017 Aug 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28789631
9.
Development of hepatocellular carcinoma in Japanese patients with biopsy-proven non-alcoholic fatty liver disease: Association between PNPLA3 genotype and hepatocarcinogenesis/fibrosis progression.
Hepatol Res;
47(11): 1083-1092, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27862719
10.
Effect of sodium glucose cotransporter 2 inhibitor on liver function tests in Japanese patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus.
Hepatol Res;
47(10): 1072-1078, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27925353
11.
Effect of 12-week dulaglutide therapy in Japanese patients with biopsy-proven non-alcoholic fatty liver disease and type 2 diabetes mellitus.
Hepatol Res;
47(11): 1206-1211, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27917557
12.
A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkers.
Hepatology;
62(5): 1433-43, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26199205
13.
Comparisons of dietary intake in Japanese with non-alcoholic fatty liver disease and type 2 diabetes mellitus.
J Clin Biochem Nutr;
59(3): 215-219, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27895389
14.
Colonic Dieulafoy lesion successfully treated by endoclips: a rare cause of lower gastrointestinal bleeding.
Endoscopy;
52(2): E49-E50, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31499536
15.
Human placental extract treatment for non-alcoholic steatohepatitis non-responsive to lifestyle intervention: A pilot study.
Hepatol Res;
45(9): 1034-1040, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25297827
16.
Predictors of malignancies and overall mortality in Japanese patients with biopsy-proven non-alcoholic fatty liver disease.
Hepatol Res;
45(7): 728-38, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25165040
17.
Lower levels of insulin-like growth factor-1 standard deviation score are associated with histological severity of non-alcoholic fatty liver disease.
Hepatol Res;
45(7): 771-81, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25163357
18.
Serum alanine aminotransferase predicts the histological course of non-alcoholic steatohepatitis in Japanese patients.
Hepatol Res;
45(10): E53-61, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25429984
19.
Efficacy and safety of sorafenib in very elderly patients aged 80 years and older with advanced hepatocellular carcinoma.
Hepatol Res;
44(13): 1329-38, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24528772
20.
The 'donations for decreased ALT (D4D)' prosocial behavior incentive scheme for NAFLD patients.
J Public Health (Oxf);
36(4): 629-34, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24099735